Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Screening Brain MRIs in Stage IV Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude
- Status
- UNKNOWN
- Phase
- N/A
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)
- Status
- UNKNOWN
- Phase
- PHASE4
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Investigating the Long-term Cardiac Sequelae of Trastuzumab Therapy
- Status
- UNKNOWN
- Phase
- N/A
Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Comparing Efficacy and Safety Between Pertuzumab® and Perjeta® in Neoadjuvant Treatment of HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ATEMPT 2.0: Adjuvant T-DM1 vs TH
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2